DK0996462T3 - Farmaceutiske kombinationspræparater indeholdende erythropoietin og modificerede hæmoglobiner - Google Patents

Farmaceutiske kombinationspræparater indeholdende erythropoietin og modificerede hæmoglobiner

Info

Publication number
DK0996462T3
DK0996462T3 DK98930785T DK98930785T DK0996462T3 DK 0996462 T3 DK0996462 T3 DK 0996462T3 DK 98930785 T DK98930785 T DK 98930785T DK 98930785 T DK98930785 T DK 98930785T DK 0996462 T3 DK0996462 T3 DK 0996462T3
Authority
DK
Denmark
Prior art keywords
preparations containing
erythropoietin
pharmaceutical preparations
combination pharmaceutical
containing erythropoietin
Prior art date
Application number
DK98930785T
Other languages
Danish (da)
English (en)
Inventor
Paul Lehmann
Michael-Harold Town
Juergen Feuerstein
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK0996462T3 publication Critical patent/DK0996462T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98930785T 1997-06-21 1998-06-03 Farmaceutiske kombinationspræparater indeholdende erythropoietin og modificerede hæmoglobiner DK0996462T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97110168A EP0885613A1 (de) 1997-06-21 1997-06-21 Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
PCT/EP1998/003299 WO1998058660A1 (de) 1997-06-21 1998-06-03 Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
EP98930785A EP0996462B1 (de) 1997-06-21 1998-06-03 Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine

Publications (1)

Publication Number Publication Date
DK0996462T3 true DK0996462T3 (da) 2004-11-29

Family

ID=8226937

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98930785T DK0996462T3 (da) 1997-06-21 1998-06-03 Farmaceutiske kombinationspræparater indeholdende erythropoietin og modificerede hæmoglobiner

Country Status (15)

Country Link
US (3) US6440932B1 (enExample)
EP (2) EP0885613A1 (enExample)
JP (3) JP2002504913A (enExample)
KR (1) KR100519904B1 (enExample)
CN (1) CN1185010C (enExample)
AT (1) ATE272405T1 (enExample)
AU (1) AU743475B2 (enExample)
BR (1) BR9810267A (enExample)
CA (1) CA2294448C (enExample)
DE (1) DE59811768D1 (enExample)
DK (1) DK0996462T3 (enExample)
ES (1) ES2226151T3 (enExample)
PT (1) PT996462E (enExample)
TR (1) TR199903192T2 (enExample)
WO (1) WO1998058660A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ337465A (en) * 1997-03-18 2002-04-26 Roche Diagnostics Gmbh Pharmaceutical containing erythropoietin and iron preparations for treating haemodialysis patients or anaemias
US7345019B1 (en) * 1999-04-13 2008-03-18 The Kenneth S. Warren Institute, Inc. Modulation of excitable tissue function by peripherally administered erythropoietin
JP3967594B2 (ja) * 2000-05-15 2007-08-29 エフ．ホフマン−ラ ロシュ アーゲー 新しい薬剤組成物
CA2431964C (en) 2000-12-20 2013-09-10 F. Hoffmann-La Roche Ag Conjugates of erythropoietin (pep) with polyethylene glycol (peg)
US20030072737A1 (en) * 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
US7767643B2 (en) 2000-12-29 2010-08-03 The Kenneth S. Warren Institute, Inc. Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
US7459435B2 (en) * 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) * 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
JP2007517769A (ja) 2003-09-29 2007-07-05 ウォーレン ファーマシューティカルズ，インコーポレーテッド 敗血症および癒着形成の治療および予防のための組織保護性サイトカイン
RU2273485C2 (ru) * 2004-05-19 2006-04-10 Виктор Николаевич Алейников Железосодержащий препарат "феррал"
US7772182B2 (en) * 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
WO2008019214A1 (en) 2006-08-04 2008-02-14 Prolong Pharmaceuticals, Inc. Modified erythropoietin
CL2008002053A1 (es) 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
CL2008002054A1 (es) 2007-07-17 2009-05-29 Hoffmann La Roche Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
EP3380487B1 (en) 2015-11-23 2020-09-02 Bristol-Myers Squibb Company Additive systems for use in protein pegylation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
US4826811A (en) * 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
JP2858752B2 (ja) * 1987-04-10 1999-02-17 オーソ・フアーマシユーチカル・コーポレーシヨン 正常な哺乳動物のヘマトクリツト値の増大方法
JPH03112934A (ja) * 1989-09-27 1991-05-14 Mitsubishi Kasei Corp 圧縮成型可能な粉体組成物
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
CA2180529A1 (en) * 1994-11-17 1996-05-30 John Blue Hemoglobin therapy in hemodialysis
DE19535571A1 (de) * 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
DE69727241D1 (de) * 1996-08-27 2004-02-19 Hemosol Inc Gesteigerte stimulation der erythropoesis

Also Published As

Publication number Publication date
BR9810267A (pt) 2000-09-12
KR20010014075A (ko) 2001-02-26
CN1185010C (zh) 2005-01-19
EP0885613A1 (de) 1998-12-23
CA2294448A1 (en) 1998-12-30
US20020160956A1 (en) 2002-10-31
JP2011246474A (ja) 2011-12-08
EP0996462B1 (de) 2004-08-04
US20050197281A1 (en) 2005-09-08
PT996462E (pt) 2004-12-31
JP2002504913A (ja) 2002-02-12
KR100519904B1 (ko) 2005-10-10
ATE272405T1 (de) 2004-08-15
AU8109898A (en) 1999-01-04
CN1261282A (zh) 2000-07-26
DE59811768D1 (de) 2004-09-09
TR199903192T2 (xx) 2000-05-22
US6440932B1 (en) 2002-08-27
AU743475B2 (en) 2002-01-24
JP5785008B2 (ja) 2015-09-24
WO1998058660A1 (de) 1998-12-30
CA2294448C (en) 2007-12-11
ES2226151T3 (es) 2005-03-16
EP0996462A1 (de) 2000-05-03
JP2007246530A (ja) 2007-09-27

Similar Documents

Publication Publication Date Title
PT996462E (pt) Preparados de combinacoes farmaceuticas contendo eritropoietina e hemoglobinas modificadas
NZ236823A (en) Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance
ES2139678T3 (es) Uso de eritropoyetina para la preparacion de una composicion farmaceutica para administracion pulmonar o inhalacion.
DK0705275T3 (da) AspB28-insulin-krystaller
DK0582239T3 (da) Farmaceutisk og/eller kosmetisk formulering
ATE223204T1 (de) Liposomenzusammensetzung
DK0851762T3 (da) Farmaceutiske kombinationspræparater, som indeholder erythropoietin og jernpræparater
AU570328B2 (en) Solid medicament formulations containing dihydropyridines
DK0437388T3 (da) Præparater indeholdende aktive bestanddele, som er beskyttet mod nedbrydning i drøvtyggeres vom
AU2231688A (en) Stabilisation of therapeutically active proteins in a pharmaceutical composition
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
DE59707988D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate
BR9910454A (pt) Preparações efervescentes
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
IL85651A0 (en) Optically active oxo-isoindolinyl derivatives,their preparation and pharmaceutical compositions containing them
KR900700471A (ko) 신규의 2,3-티오모르폴린디온-2-옥심유도체, 이들을 함유하는 약제학적 조성물 및 제법
EP0418065A3 (en) Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same
TR199902305T2 (xx) Eritropoitein ve demir preperasyonları içeren farmasötik birleşimli preperasyonlar.
ATE45956T1 (de) 11 beta-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate.
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
ATE53214T1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
ATE49956T1 (de) N,n-bis-(4fluorophenyl)carbamoylacetohydroxams|ure und diese enthaltende pharmazeutische zusammensetzungen.
IL103676A0 (en) Pharmaceutical compositions containing hemoglobins as drug delivery agents and methods for the preparation thereof